Daniel Pipeleers, MD, PhD. Between 1971 and 1980, investigator Belgian Research Foundation and Harkness Fellow Commonwealth Foundation at Université Libre de Bruxelles, Washington University St Louis, Queen Elisabeth Foundation Brussels. Since 1980, professor at Vrije Universiteit Brussel-VUB and since 1987 consultant at University Hospital, Brussels. Since 1990, director VUB-Diabetes Research Center where expertise in beta cell biology, pathology and therapy guides strategies and trials for early diagnosis, prevention and treatment of type 1 diabetes. Founder of cell therapy company Beta-Cell nv, and two networks for clinical translation, the Belgian Diabetes Registry with associated Diabetes Biobank, and the Consortium for Beta Cell Therapy in Diabetes. Since 2002 director of international Beta Cell Therapy program, supported by European Union and Juvenile Diabetes Research Foundation. 
Dr Pipeleers is Honorary Doctor at Uppsala University, Sweden, member of the Belgian Royal Academy of Medicine, recipient of twelve (inter)national awards in medical sciences. He serve(s)(d) as board member and advisor in academic, clinical and governmental institutions, in scientific and bioindustrial organizations.